Our Businesses
Our Company
Share
Back to top
Depression
-
Injections that allow people with schizophrenia to go longer between treatments. Digital tools that may lead to the creation of more effective medications. Programs that ensure mental illness is properly diagnosed. These are just a few of the ways Johnson & Johnson is addressing the largest unmet need in healthcare.
-
Plenty of things can come between you and a good night’s sleep: stress, anxiety and pain, to name a few. In honor of Better Sleep Month, take this quiz to test your insomnia IQ—and get expert-approved tips on how to up the number of Zzzs you get every night.
-
As the pandemic spread, many young people experienced anger, stress—even depression. But a Save the Children initiative supported by Johnson & Johnson is teaching them how to manage their difficult emotions.
-
Meet four students dedicated to removing the stigma of mental illness and increasing access to crucial treatments around the world—with the help of the Global Mental Health Scholarship Fund.
-
As a teenager, Wayne Drevets, M.D., had friends who struggled with depression—and who ultimately inspired him to focus his career on helping people with the debilitating disorder.
-
A staggering 1 in 7 women suffer from perinatal mood disorders, which can begin as early as pregnancy. We take a look at how these scientists are working to find ways to help halt depression in moms at the most critical juncture: before it starts.
-
From scientists in research labs to CEOs at companies across the country, here's how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
-
Imade Nibokun Borha, 31, shares the raw truth about living with treatment-resistant depression—and the surprising silver lining she's found through her diagnosis.
-
From breakthrough work to eradicate some of the world's deadliest diseases to advancements in cutting-edge health technology, see just some of the ways Johnson & Johnson is working to help change the trajectory of health for humanity.
-
Joe Wolk, who has enjoyed a 20-year tenure at Johnson & Johnson, shares his vision for the company's fiscal future.
-
Imagine being depressed and trying medication after medication—only to find none work. That's the plight of people with treatment-resistant depression. We look at this little-understood condition, and how researchers are working to crack its code.
-
With company leaders at the World Economic Forum in Davos this week, Johnson & Johnson's Chief Scientific Officer weighs in on the next great global healthcare challenge—and how we can all come together to help address it.
-
Make this the year you finally feel rested—with some help from these top sleep researchers.
-
It's a complicated illness, with no exact cause, but there is still a lot we now understand about depression, thanks to the work of dedicated scientists. For World Mental Health Day, we look at the facts, common misconceptions and research that's underway.
-
Husseini Manji, M.D., is working toward a world in which diseases like depression and schizophrenia are diagnosed quickly and handled without stigma. His team's discoveries in the lab may just get us there.
